Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855373 · ClinicalTrials.gov registry record · NA
Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01855373 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 60 participants.
The verdict
NCT01855373, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To purpose of this study is to assess the effectiveness, safety and tolerability of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® on levels of blood sugar and endothelial function improvement which may lead to improved vascular health.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT PEAK ATP® with GlycoCarn®
- DIETARY_SUPPLEMENT PEAK ATP®
- DIETARY_SUPPLEMENT GlycoCarn®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01855373
The ClinicalTrials.gov registry entry for NCT01855373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Supplement Formulators, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01855373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01855373 about?
NCT01855373 is a clinical study titled "Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements". To purpose of this study is to assess the effectiveness, safety and tolerability of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® on levels of blood sugar and endothelial function improvement which may lead to improved vascular health.
What is the current status of trial NCT01855373?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01855373?
The interventions under investigation include: Placebo (OTHER), PEAK ATP® with GlycoCarn® (DIETARY_SUPPLEMENT), PEAK ATP® (DIETARY_SUPPLEMENT), GlycoCarn® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01855373?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.